Test Price
2,800 AED✅ Home Collection Available
KCNQ1 Gene Atrial Fibrillation Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين KCNQ1 المرتبط بالرجفان الأذيني من النوع الثالث بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: فحص جيني متكامل لتحديد الطفرات المسببة للرجفان الأذيني الوراثي (النوع الثالث) عبر جين KCNQ1. دقة تشخيصية تبلغ 99.9% باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) وفقًا لمعايير الآيزو 9001:2015. يتضمن سحبًا منزليًا بمواصفات النقل المبرد المعتمد، واستشارة هاتفية متخصصة لتفسير النتائج، وقبول التأمين الصحي عبر واتساب.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
What is the KCNQ1 Gene Atrial Fibrillation Type 3 Test?
This advanced genetic test sequences the KCNQ1 gene to identify pathogenic variants responsible for familial atrial fibrillation type 3, enabling early risk stratification and personalised management. اختبار جيني للكشف عن طفرات الرجفان الأذيني الوراثي من النوع الثالث.
| Feature | Our NGS Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% full-gene coverage (NGS) | Limited single-gene Sanger panels |
| Methodology | Next-Generation Sequencing (NGS) – Illumina platform | PCR-based fragment analysis / older platforms |
| Turnaround Time | 3–4 weeks | 4–6 weeks (external referral) |
| Post-test Genetic Counselling | Included (telephonic) | Often not included |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA: 61713011): “Detecting a KCNQ1 mutation can unlock life-saving rhythm control strategies, but a positive result must be interpreted within the full clinical picture—family history, ECG patterns, and symptom burden remain essential. I encourage every patient to share these results with their electrophysiologist or cardiologist for a personalised care plan.”
Do not discontinue prescribed medication (e.g., antiarrhythmics, anticoagulants) without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Active haemodynamic instability or acute coronary syndrome – seek immediate emergency care, not a genetic test.
- Known pregnancy is not a contraindication, but postpone testing if medically unnecessary during an acute episode.
- Minors require a legal guardian’s consent in compliance with CDS Law 2026.
- ER Red Flags: Sudden loss of consciousness, severe chest pain with palpitations, or signs of stroke – call 998 immediately.
Pre-test Information & Preparation
- Provide a comprehensive clinical history, including symptom onset and family history of atrial fibrillation or sudden cardiac death.
- A genetic counselling session to draw a detailed pedigree chart is mandatory before sample collection (included in the test).
- Samples accepted: Whole Blood (EDTA), Extracted DNA, or one drop of blood on an FTA card – all collected under strict cold-chain protocols.
- No fasting required; continue routine medications unless specifically directed by your physician.
Frequently Asked Questions (FAQs)
1. How accurate is the KCNQ1 gene test for atrial fibrillation type 3?
Our NGS-based test achieves >99.9% analytical sensitivity and specificity for detecting clinically significant KCNQ1 variants when performed on high-quality DNA samples, and all results are confirmed through bidirectional sequencing and bioinformatics pipelines aligned with international guidelines.
2. كم يستغرق ظهور نتيجة تحليل جين KCNQ1 للرجفان الأذيني الوراثي؟
تظهر النتيجة خلال 3 إلى 4 أسابيع من استلام العينة في المختبر، مع إمكانية تسريعها في حالات الطوارئ السريرية بعد التواصل المباشر مع الفريق الطبي عبر واتساب.
3. Is a KCNQ1 mutation always associated with atrial fibrillation, and what if my result is negative?
Not all KCNQ1 variants are pathogenic; a negative does not exclude other genetic or acquired causes of atrial fibrillation, and clinical follow‑up with an electrophysiologist remains essential for comprehensive risk assessment and management of arrhythmia.
UAE Regulatory & Data Privacy Compliance
- Testing adheres to Federal Decree‑Law No. 41 of 2024 on Medical Liability, Article 87 (Genetic Testing Regulations).
- Compliant with CDS Law 2026 for minor consent – a legal guardian’s approval is mandatory for patients under 18.
- UAE PDPL (Federal Decree‑Law No. 45 of 2021) governs the storage and sharing of genetic data; all information is encrypted and processed on UAE‑based servers.
- ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139) – ensuring worldwide laboratory quality standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians